Content Areas (Codes):
The following Content Areas will be printed on the certificate for this course:
- Gastrointestinal Radiology
- Magnetic Resonance Imaging
- Oncologic Imaging
Course Learning Objectives:
- Review scientific evidence behind HCC screening and surveillance.
- Review current AASLD/EASL guidelines for HCC screening/surveillance.
- Introduce the concept of abbreviated MRI (AMRI) for HCC screening and surveillance.
- Review early results and future directions of AMRI for HCC screening.
- Review imaging guidelines for diagnosis of hepatocellular carcinoma, including AASLD, LI-RADS and OPTN.
- Discuss differences in intended users and patient population for these guidelines.
- Illustrate how management options influence the desired specificity of imaging diagnosis for HCC.
- Recognize a pathological category called early HCCs or hypovascular HCCs.
- Explain the concept of hypovascular hypointense nodule in gadoxetic acid-enhanced MRI.
- Discuss the recent development of new treatments of HCC, including systemic chemotherapy and intervention.
- Describe the rationale for a relevant follow-up of treatment efficacy.
- Identify the different standards for imaging follow-up.
This enduring material is estimated to take 1 hour to complete.
Online Course Start Date: 1/19/2018
End Date for CME Eligibility/Online Expiration Date: 1/18/2021
This educational activity was originally presented at the RSNA 2016 Annual Meeting and Scientific Assembly. This course was co-presented by Society of Abdominal Radiology (SAR), Japanese Society of Abdominal Radiology (JSAR), Korean Society of Abdominal Radiology (KSAR) and French Society of Abdominal Radiology (SIAD).
Authors:
- Bachir Taouli, MD
- Cynthia S. Santillan, MD
- Utaroh Motosugi, MD
- Yves M. Menu, MD
Disclosure Statements:
The ACCME requires that the RSNA, as an accredited provider of CME, disclose the relevant financial relationships of the planners, faculty, and any other individuals in a position to control content of this activity. If there is a relevant financial relationship that has been disclosed please find it below:
- Suhny Abbara, MD: Author, Reed Elsevier; Editor, Reed Elsevier; Institutional Research Agreement, Koninklijke Philips NV, Siemens AG.
- David A. Bluemke, MD, PhD: Research support, Siemens AG.
- William W. Boonn, MD: Founder, Montage Healthcare Solutions, Inc; President, Montage Healthcare Solutions, Inc; Shareholder, Montage Healthcare Solutions, Inc, Nuance Communications, Inc.
- Kristy K. Brock, PhD: License agreement, RaySearch Laboratories AB; Development agreement, Varian Medical Systems, Inc.
- Dorothy I. Bulas, MD: Editor, Wolters Kluwer NV.
- Dominik Fleischmann, MD: Research support, Siemens AG.
- Brian S. Funaki, MD: Data Safety Monitoring Board, Novate Medical Ltd.
- Jean-Francois H. Geschwind, MD: Consultant, BTG International Ltd, Bayer AG, Guerbet SA, Sterigenics International, LLC, Koninklijke Philips NV, Jennerex Biotherapeutics, Inc; Grant, BTG International Ltd, Bayer AG, Koninklijke Philips NV, Sterigenics International LLC, Threshold Pharmaceuticals, Inc, Guerbet SA; Founder and CEO, PreScience Labs, LLC.
- Christopher P. Hess, MD, PhD: Research Grant, General Electric Company, Quest Diagnostics Incorporated, Cerebrotech Medical Systems, Inc; Speaker, Siemens AG.
- Vincent B. Ho, MD, MBA: In-kind support, General Electric Company.
- Herbert Y. Kressel, MD: Stockholder, Pfizer Inc, GlaxoSmithKline plc.
- Cherie M. Kuzmiak, DO: Research Grant, FUJIFILM Holdings Corporation.
- Simon S. Lo, MD: Research support, Elekta AB; Travel support, Accuray Incorporated; Speaker, Accuray Incorporated.
- H. Page McAdams, MD: Research Grant, General Electric Company; Consultant, MedQIA Imaging Core Laboratory; Author, Reed Elsevier; Author, UpToDate, Inc; Research Consultant, F. Hoffmann-La Roche Ltd, Boehringer-Ingelheim GmbH.
- Charles E. Ray Jr., MD, PhD: Data Safety Monitoring Board, Novate Medical Ltd; Editor, Thieme Medical Publishers, Inc; Consultant, W. L. Gore & Associates, Inc, Medtronic plc.
- Ehsan Samei, PhD: Research Grant, General Electric Company; Research Grant, Siemens AG.
- Stuart G. Silverman, MD: Author, Wolters Kluwer nv.
- Christina I. Tsien, MD: Speaker, Merck & Co, Inc.
- William J. Weadock, MD: Owner, Weadock Software, LLC.
- Charles E. Willis, PhD: Medical Advisory Board, General Electric Company.
- Won Jae Lee, MD: Research Grant, Samsung Electronics Co, Ltd.
- Cynthia S. Santillan, MD: Consultant, Robarts Clinical Trials, Inc.
- Bachir Taouli, MD: Consultant, MEDIAN Technologies; Grant, Guerbet SA.
- Judy Yee, MD: Research Grant, EchoPixel, Inc.
All other individuals in control of content have indicated that they have no relevant financial relationships to disclose for this activity.
Accreditation and Designation Statements:
The Radiological Society of North America (RSNA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
This enduring material can be applied towards the ABR MOC self-assessment requirement (SA-CME).
To earn CME credit, participants must correctly answer a minimum of 80% of the post-test questions and complete the course evaluation.
The RSNA designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Price:
Non-member Rate: $50.00
Member Rate: $0.00
Refund / Exchange Policy:
RSNA will not issue any refunds or exchanges for online only versions of educational products or activities purchased online. Please review the entire product or activity description prior to purchase.
RSNA Disclaimer:
The opinions or views expressed in this activity are those of the presenters and do not necessarily reflect the opinions, recommendations or endorsement of the RSNA. Participants should critically appraise the information presented and are encouraged to consult appropriate resources for information surrounding any product or device mentioned. Information presented, as well as publications, technologies, products and/or services discussed, are intended to inform the learner about the knowledge, techniques, and experiences of RSNA faculty who are willing to share such information with colleagues. The RSNA disclaims any and all liability for damages to any individual user for all claims which may result from the use of said information, publications, technologies, products and/or services, and events.